Key facts
- Crosby Health’s last known valuation is $11.5M (Feb 2026).
- It has raised $3.0M; the latest was Seed Round ($830K) in Feb 2026.
- Notable investors include Amplo, NOMO Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Crosby Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Crosby Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Crosby Health
Developer of a medical documentation correction software designed to automate tasks and ensure accurate reimbursement for healthcare providers. The company's software uses clinical artificial intelligence, natural language processing, expert appeal writers and a submission engine to automate the creation of clinical appeal letters and streamline revenue cycle management, enabling healthcare providers to streamline healthcare processes, improve appeal outcomes and focus on patient care.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 14
- Website
- crosbyhealth.com/
- Ownership
- Privately Held (backing)
Crosby Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Crosby Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Crosby Health in its N-PORT filings yet. We sweep new filings monthly.